Close

Evaxion Biotech A/S (EVAX) Prices 3M ADS IPO at $10/ADS

Go back to Evaxion Biotech A/S (EVAX) Prices 3M ADS IPO at $10/ADS

Evaxion Biotech Announces Pricing of Initial Public Offering

February 4, 2021 4:16 PM EST

COPENHAGEN, Denmark, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Evaxion), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, today announced the pricing of its initial public offering of 3,000,000 American Depositary Shares (ADSs), at a public offering price of $10 per ADS, with each such ADS representing one ordinary share, DKK 1 nominal value per share, of Evaxion (Ordinary Shares). The gross proceeds from the offering are expected to be approximately $30 million before deducting underwriting fees and commissions and other offering expenses. Evaxion has granted the underwriters... More